Second, we have chosen the hepatocellular carcinoma cell line Hep3B because of its low endogenous SP8 expression as a study model for inducible SP8 gain-of function experiments, which might display some tumor properties distinct from HB. This evidence concerns the gene SP8 and neoplasm.